Atlas FDA

GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis

FDA premarket approval P230023/S001 · decided 2024-03-22

Approval details

PMA number
P230023
Supplement
S001
Supplement type
Normal 180 Day Track No User Fee
Supplement reason
Postapproval Study Protocol
Trade name
GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis
Generic name
Endovascular system for treatment of thoracoabdominal and pararenal aortic lesions
Applicant
W. L. Gore & Associates, Inc.
Date received
2024-02-08
Decision date
2024-03-22
Days to decision
43 days
Decision code
APPR
Product code
QZK
Advisory committee
Cardiovascular
Expedited review
No
Location
Flagstaff, AZ
Statement
approval of the protocol for the post-approval study (PAS) referenced above. The PAS protocol has been submitted to comply with the conditions of approval outlined in our approval order for P230023.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
GORE® Tri-Lobe Balloon Catheter (K250410)W. L. Gore & Associates, Inc.2025-06-02
GORE® PROPATEN® Vascular Graft (K240083)W. L. Gore & Associates, Inc.2024-03-01
GORE® PROPATEN® Vascular Graft (K232312)W. L. Gore & Associates, Inc.2024-01-09
GORE® ACUSEAL Vascular Graft (K233551)W. L. Gore & Associates, Inc.2023-12-19
GORE® ACUSEAL Vascular Graft (K231505)W. L. Gore & Associates, Inc.2023-06-23
GORE BIO-A Tissue Reinforcement (K191773)W. L. Gore & Associates, Inc.2019-07-31
GORE SEAMGUARD Bioabsorbable Staple Line Reinforcement (K181940)W. L. Gore & Associates, Inc.2018-08-17
GORE ENFORM Biomaterial (K173333)W. L. Gore & Associates, Inc.2018-04-05